影像学检查诊断非酒精性脂肪性肝病研究进展

doi:10.3969/j.issn.1672-5069.2015.02.031

摘要/Abstract

摘要： 随着健康管理的观念普及，精确地诊断和科学地管理非酒精性脂肪性肝病(NAFLD) 患者变得越来越紧迫。影像学在NAFLD 诊断中的作用越来越重要，深入研究影像学方法进行肝脏脂肪量化诊断对于NAFLD 患者的预后和健康管理有着重大而深远的意义。

关键词: 非酒精性脂肪性肝病, 影像学, 超声, 磁共振

Abstract: The accurate diagnosis and scientific management of patients with nonalcoholic fatty liver diseases （NAFLD） is becoming more and more urgent. Ultrasonography and magnetic resonance imaging are applied to the diagnosis of NAFLD in clinical practice， and the imaging methods for liver fat quantitation for patient with NAFLD are reviewed in this paper.

Key words: Nonalcoholic fatty liver diseases, Ultrasound, Magnetic resonance

周龙，张茜，佘会元. 影像学检查诊断非酒精性脂肪性肝病研究进展[J]. 实用肝脏病杂志, 2015, 18(4): 437-440.

Zhou Long， Zhang Qian，She Huiyuan. Ultrasonography and magnetic resonance imaging in diagnosis of patients with nonalcoholic fatty liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 437-440.

参考文献

[1] Leitao HS，Paulino C，Rodrigues D，et al. MR fat fraction mapping：a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients.Acad Radiol，2013，20（8）：957-961.
[2] Festi D，Schiumerini R，Marzi L，et al. Review article：the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. Aliment Pharmacol Ther，2013，37（4）：392-400.
[3] Farrell GC，Chitturi S，Lau GK，et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region：executive summary.J Gastroenterol Hepatol，2007，22（6）：775-777.
[4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南（2010年修订版）.中华肝脏病杂志，2010，18（3）：163-166.
[5] Dyson JK， Anstee QM， McPherson S. Non-alcoholic fatty liver disease：a practical approach to diagnosis and staging.Frontline Gastroenterol，2014，5（3）：211-218.
[6] Bellentani S，Scaglioni F，Marino M，et al. Epidemiology of non-alcoholic fatty liver disease.Dig Dis，2010，28（1）：155-161.
[7] Seeff LB， Everson GT，Morgan TR，et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.Clin Gastroenterol Hepatol，2010，8（10）：877-883.
[8] Webb M，Yeshua H，Zelber-Sagi S，et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis.AJR，2009，192（4）：909-914.
[9] Borges VF，Diniz AL，Cotrim HP，et al. Sonographic hepatorenal ratio：a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound，2013，41（1）：18-25.
[10] Kwon HJ，Kim KW，Lee SJ，et al. Value of the ultrasound attenuation index for noninvasive quantitative estimation of hepatic steatosis. J Ultrasound Med，2013，32（2）：229-235.
[11] Thijssen JM，Starke A，Weijers G，et al. Computer-aided b-mode ultrasound diagnosis of hepatic steatosis：a feasibility study. IEEE Trans Ultrason Ferroelectr Freq Control，2008，55：1343-1354．
[12] Liu KH， Chan YL，Chan JC，et al. Mesenteric fat thickness as an independent determinant of fatty liver. Int J Obes （Lond），2006，30（5）：787-793.
[13] Kim HJ，Cho MH，Park JS，et al. Visceral fat thickness predicts fatty liver in Koreans with type 2 diabetes mellitus. J Korean Med Sci，2008，23（2）：256-261.
[14] Illouz F，Roulier V，Rod A，et al. Distribution of adipose tissue：quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome. Diabetes Metab，2008，34（1）：68-74.
[15] 刘玉蕾，曹军英，张筠. 应用超声组织定征视频法评价脂肪肝程度. 中国医学工程，2012，6（20）：3-5.
[16] Fitzpatrick E，Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease：Current status and a glimpse of the future. World J Gastroenterol，2014，20（31）：10851-10863.
[17] Wong GL，Wong VW，Chan HL. Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease J Hepatol，2011，55（2）：497-498.
[18] Sasso M，Beaugrand M，de Ledinghen V，et al. Controlled attenuation parameter （CAP）：a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis： preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol，2010，36（11）：1825-1835.
[19] Ricci C，Longo R，Gioulis E，et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol，1997，（1）：108-113.
[20] Park SH，Kim PN，Kim KW，et al. Macrovesicular hepatic steatosis in living liver donors：use of CT for quantitative and qualitative assessment.Radiology，2006，239（1）：105-112.
[21] Kodama Y，Ng CS，Wu TT，et al. Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol，2007，188（5）：1307-1312.
[22] Kim DY，Park SH，Lee SS，et al. Gastrointestinal contrast-enhanced computed tomography for the diagnosis of fatty liver：prospective study with same-day biopsy used as the reference standard.Eur Radiol，2010，20：359-366.
[23] Park YS，Park SH，Lee SS，et al. Biopsy-proven nonsteatotic liver in adults：estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT.Radiology，2011，258（3）：760-766.
[24] Panicek DM，Giess CS，Schwartz LH. Qualitative assessment of liver for fatty infiltration on contrast-enhanced CT：is muscle a better standard of reference than spleen J Comput Assist Tomogr，1997，21（5）：699-705.
[25] Pacifico L，Celestre M，Anania C，et al. MRI and ultrasound for hepatic fat quantification：relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr，2007，96（4）：542-547.
[26] Talwalkar JA，Yin M，Fidler JL，et al. Magnetic resonance imaging of hepatic fibrosis：emerging clinical applications.Hepatology，2008，47（1）：332-342.
[27] Jiménez-Agüero R，Emparanza JI，Beguiristain A，et al. Novel equation to determine the hepatic triglyceride concentration in humans by MRI：diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery. BMC Med，2014，12（1）：137.
[28] Chalasani N，Younossi Z，Lavine JE，et al. The diagnosis and management of non-alcoholic fatty liver disease：Practice guideline by the American Association for the Study of Liver Diseases，American College of Gastroenterology，and the American Gastroenterological Association.Am J Gastroenterol，2012，107（6）：811-826.
[29] Thomas EL，Hamilton G，Patel N，et al. Hepatic triglyceride content and its relation to body adiposity：a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut，2005，54（1）：122-127.
[30] Heath ML，Kow L，Slavotinek JP，et al. Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery. Metabolism，2009，58（6）：753-758.
[31] Kantartzis K，Machicao F，Machann J，et al. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. Clin Sci（Lond），2009，116（6）：531-537.
[32] Silbernagel G，Kovarova M，Cegan A，et al. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. J Clinc Endocrinol Metab，2012，97（12）：E2288-2292.
[33] Tang A，Tan J，Sun M，et al. Nonalcoholic fatty liver disease：MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology，2013，267（2）：422-431.
[34] Noureddin M，Lam J，Peterson MR，et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology，2013，58（6）：1930-1940.
[35] Permutt Z，Le TA，Peterson MR，et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease-MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther，2012，36（1）：22-29.